{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:32:13Z","timestamp":1761129133988},"reference-count":11,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jbspin.2014.03.003","type":"journal-article","created":{"date-parts":[[2014,4,18]],"date-time":"2014-04-18T11:05:05Z","timestamp":1397819105000},"page":"445-446","source":"Crossref","is-referenced-by-count":19,"title":["Acute ocular myositis occurring under etanercept for rheumatoid arthritis"],"prefix":"10.1016","volume":"81","author":[{"given":"Marion","family":"Couderc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Tournadre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Jacques","family":"Dubost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Soubrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2014.03.003_bib0005","first-page":"37","article-title":"Ocular myositis: diagnostic assessment, differential diagnoses, and therapy of a rare muscle disease\u00a0\u2013\u00a0five new cases and review","volume":"1","author":"Schoser","year":"2007","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jbspin.2014.03.003_bib0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jbspin.2013.06.001","article-title":"IgG4-related disease","volume":"81","author":"Palazzo","year":"2014","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2014.03.003_bib0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11882-008-0054-2","article-title":"Biologic agents in the management of inflammatory eye diseases","volume":"8","author":"Michalova","year":"2008","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jbspin.2014.03.003_bib0020","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases","volume":"86","author":"Ramos-Casals","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2014.03.003_bib0025","article-title":"Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)","author":"Tournadre","year":"2013","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jbspin.2014.03.003_bib0030","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.22477","article-title":"A randomized, pilot trial of etanercept in dermatomyositis","volume":"70","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jbspin.2014.03.003_bib0035","first-page":"136","article-title":"Orbital myositis in a rheumatoid arthritis patient during etanercept treatment","volume":"21","author":"Caramaschi","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2014.03.003_bib0040","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1590\/S0004-282X2000000100027","article-title":"Orbital myositis and rheumatoid arthritis: case report","volume":"58","author":"Panfilio","year":"2000","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.jbspin.2014.03.003_bib0045","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10067-009-1370-1","article-title":"Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature","volume":"29","author":"Ishikawa","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2014.03.003_bib0050","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ajo.2004.06.077","article-title":"Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab","volume":"138","author":"Garrity","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jbspin.2014.03.003_bib0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.semarthrit.2006.02.001","article-title":"Tumor necrosis factor antagonists: different kinetics and\/or mechanisms of action may explain differences in the risk for developing granulomatous infection","volume":"36","author":"Furst","year":"2006","journal-title":"Semin Arthritis Rheum"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X1400061X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X1400061X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T21:25:58Z","timestamp":1538688358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X1400061X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1297319X1400061X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2014.03.003","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}